Propagermanium has been reported to successfully reduce brain edema and improve neurobehavioral functions by suppression of CCL2‐CCR2‐p38 MAPK pathway following intracerebral hemorrhage (Guo et al., 2020). Here, CCR2 is linked to brain edema.